Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer. | Cancer Immunol Res | 2023 | 37172100 | PubTator, text mining | PubMed |
| Novel potential therapeutic targets of alopecia areata. | Front Immunol | 2023 | 37153617 | PubTator, text mining | PubMed |
| Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review). | Int J Oncol | 2023 | 37144487 | PubTator, text mining | PubMed |
| Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects. | Hum Vaccin Immunother | 2023 | 37128699 | PubTator, text mining | PubMed |
| Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer. | Front Genet | 2023 | 37124622 | PubTator, text mining | PubMed |
| T Cell Based Immunotherapy for Cancer: Approaches and Strategies. | Vaccines (Basel) | 2023 | 37112747 | PubTator, text mining | PubMed |
| Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM. | Nat Commun | 2023 | 37100770 | PubTator, text mining | PubMed |
| The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022. | J Transl Med | 2023 | 37087493 | PubTator, text mining | PubMed |
| Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. | Cell Mol Biol Lett | 2023 | 37085753 | PubTator, text mining | PubMed |
| Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma. | Front Immunol | 2023 | 37081889 | PubTator, text mining | PubMed |
| Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers. | Mol Cancer | 2023 | 37072770 | PubTator, text mining | PubMed |
| Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses. | Adv Biomed Res | 2023 | 37057240 | PubTator, text mining | PubMed |
| Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis. | Front Genet | 2023 | 37056286 | PubTator, text mining | PubMed |
| Novel strategies for cancer immunotherapy: counter-immunoediting therapy. | J Hematol Oncol | 2023 | 37055849 | PubTator, text mining | PubMed |
| Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups. | Front Immunol | 2023 | 37051252 | PubTator, text mining | PubMed |
| Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer. | Cancers (Basel) | 2023 | 37046621 | PubTator, text mining | PubMed |
| Research Progress of Immunotherapy for Gastric Cancer. | Technol Cancer Res Treat | 2023 | 37042029 | PubTator, text mining | PubMed |
| Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis. | Oncologist | 2023 | 37036865 | PubTator, text mining | PubMed |
| Risk stratification based on DNA damage-repair-related signature reflects the microenvironmental feature, metabolic status and therapeutic response of breast cancer. | Front Immunol | 2023 | 37033959 | PubTator, text mining | PubMed |
| Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. | Signal Transduct Target Ther | 2023 | 37029123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=13